Drugs Safety AlertFDA Adds New Safety Warning to ALTUVIIIO Label FDA Adds New Safety Warning to ALTUVIIIO Label Read Post »
New Drug ApprovalPharming Wins FDA Approval to Expand Joenja to Children With APDS Pharming Wins FDA Approval to Expand Joenja to Children With APDS Read Post »
Health TidingsFDA Extends Review of Zanzalintinib Combination in Metastatic Colorectal Ca... FDA Extends Review of Zanzalintinib Combination in Metastatic Colorectal Ca... Read Post »
New Drug ApprovalFDA Approves ISEMBYLD as First Muscle-Targeted Therapy for Spinal Muscular ... FDA Approves ISEMBYLD as First Muscle-Targeted Therapy for Spinal Muscular ... Read Post »
Health TidingsFDA Grants Orphan Drug Designation to Asedebart for Cushing’s Syndrome FDA Grants Orphan Drug Designation to Asedebart for Cushing’s Syndrome Read Post »
Health TidingsBIO101 potential GLP-1 complement advances toward Phase 2 obesity trial BIO101 potential GLP-1 complement advances toward Phase 2 obesity trial Read Post »
Health TidingsKyowa Kirin’s KHK4951 Eye Drop Misses Phase 2 Endpoint in Neovascular AMD Kyowa Kirin’s KHK4951 Eye Drop Misses Phase 2 Endpoint in Neovascular AMD Read Post »
Clinical TrialsStructure Advances Oral Obesity Pipeline With ACCG-2671 and Aleniglipron Da... Structure Advances Oral Obesity Pipeline With ACCG-2671 and Aleniglipron Da... Read Post »
Health TidingsGSK Wins Japan Approval for Ready-to-Use Shingrix Prefilled Syringe GSK Wins Japan Approval for Ready-to-Use Shingrix Prefilled Syringe Read Post »
Health TidingsImmutep Refocuses Efti Development on HNSCC and STS Immutep Refocuses Efti Development on HNSCC and STS Read Post »
Clinical TrialsRedasemtide Shows DEB Ulcer Closure, Misses Stroke Endpoint Redasemtide Shows DEB Ulcer Closure, Misses Stroke Endpoint Read Post »
Clinical TrialsFinal MATTERHORN Analysis Confirms Overall Survival Benefit With Durvalumab... Final MATTERHORN Analysis Confirms Overall Survival Benefit With Durvalumab... Read Post »
Health TidingsFirst Generative AI-Discovered Drug Advances to Phase III Human Studies First Generative AI-Discovered Drug Advances to Phase III Human Studies Read Post »
Clinical TrialsSetmelanotide Shows BMI and Metabolic Benefits in Paediatric Hypothalamic O... Setmelanotide Shows BMI and Metabolic Benefits in Paediatric Hypothalamic O... Read Post »
Clinical TrialsAtogepant Cuts Menstrual Migraine Days in Phase 3 LUNA Study Atogepant Cuts Menstrual Migraine Days in Phase 3 LUNA Study Read Post »
Clinical TrialsTNP-2092 Shows 100% Six-Month Success in Phase IIa Non-Surgical PJI Trial TNP-2092 Shows 100% Six-Month Success in Phase IIa Non-Surgical PJI Trial Read Post »
Clinical TrialsFDA Pauses New Enrollment in Biohaven’s Opakalim Epilepsy Program Over Ro... FDA Pauses New Enrollment in Biohaven’s Opakalim Epilepsy Program Over Ro... Read Post »
Clinical TrialsOpus Genetics Reports Visual Function Gains with OPGx-BEST1 in Phase 1/2 BE... Opus Genetics Reports Visual Function Gains with OPGx-BEST1 in Phase 1/2 BE... Read Post »
Clinical TrialsTT-P34 Phase 1 Trial Shows CNS Exposure in Parkinson’s TT-P34 Phase 1 Trial Shows CNS Exposure in Parkinson’s Read Post »
Health TidingsRoche’s Enspryng Wins FDA Priority Review for MOGAD After 68% Relapse-Ris... Roche’s Enspryng Wins FDA Priority Review for MOGAD After 68% Relapse-Ris... Read Post »
Clinical TrialsVOXZOGO (Vosoritide) Shows Significant Growth Improvements in Phase 3 Hypoc... VOXZOGO (Vosoritide) Shows Significant Growth Improvements in Phase 3 Hypoc... Read Post »
Clinical TrialsNeflamapimod Biomarker Data Set to Shed Light on Tau-Driven FTD in Phase 2a... Neflamapimod Biomarker Data Set to Shed Light on Tau-Driven FTD in Phase 2a... Read Post »
Clinical TrialsDISC-3405 Reduces Phlebotomy and Controls Hematocrit in Phase 2 Polycythemi... DISC-3405 Reduces Phlebotomy and Controls Hematocrit in Phase 2 Polycythemi... Read Post »
Clinical TrialsBeeline’s Afimetoran Meets Phase 2 Endpoint in SLE Beeline’s Afimetoran Meets Phase 2 Endpoint in SLE Read Post »
Health TidingsKura Oncology Spins Out Caspian Therapeutics With $50 Million to Advance Me... Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Advance Me... Read Post »
Disease & Drugs New Drug ApprovalFDA Expands Sevabertinib Approval to First-Line HER2-Mutant NSCLC FDA Expands Sevabertinib Approval to First-Line HER2-Mutant NSCLC Read Post »
Health TidingsUCB’s CIMZIA Wins FDA Breakthrough Therapy Designation for Antiphospholip... UCB’s CIMZIA Wins FDA Breakthrough Therapy Designation for Antiphospholip... Read Post »
Clinical TrialsFate Advances iPSC-Derived CAR T Pipeline With New Lupus Data Fate Advances iPSC-Derived CAR T Pipeline With New Lupus Data Read Post »
Health TidingsFDA Accepts MOGENRY BLA for Severe Retinitis Pigmentosa FDA Accepts MOGENRY BLA for Severe Retinitis Pigmentosa Read Post »
Health TidingsRezera Advances Ruvonoflast Toward Phase 3 PAD Trial Following Positive RES... Rezera Advances Ruvonoflast Toward Phase 3 PAD Trial Following Positive RES... Read Post »
Clinical TrialsEvommune Discontinues EVO756 in Atopic Dermatitis After Earlier CSU Setback Evommune Discontinues EVO756 in Atopic Dermatitis After Earlier CSU Setback Read Post »
Health TidingsDefinium Receives Second FDA Breakthrough Therapy Designation for DT120 (Ly... Definium Receives Second FDA Breakthrough Therapy Designation for DT120 (Ly... Read Post »
Disease & Drugs Health TidingsGlyphAllo Shows No Next-Morning Driving Impairment at 375 mg GlyphAllo Shows No Next-Morning Driving Impairment at 375 mg Read Post »
Health TidingsInfigratinib Shows Broader Clinical Benefits Beyond Growth in Children with... Infigratinib Shows Broader Clinical Benefits Beyond Growth in Children with... Read Post »
Clinical TrialsCOMP360 Shows 52-Week Benefit in Treatment-Resistant Depression COMP360 Shows 52-Week Benefit in Treatment-Resistant Depression Read Post »
Clinical TrialsDabogratinib Posts Promising 79% Response Rate in Phase 2 Results in Bladde... Dabogratinib Posts Promising 79% Response Rate in Phase 2 Results in Bladde... Read Post »
Health TidingsVerekitug Cuts Asthma Exacerbations by 56% in Phase 2 VALIANT Trial Verekitug Cuts Asthma Exacerbations by 56% in Phase 2 VALIANT Trial Read Post »
Clinical TrialsSpyre’s SPY003 Delivers a Strong Phase 2 Signal in Ulcerative Colitis Spyre’s SPY003 Delivers a Strong Phase 2 Signal in Ulcerative Colitis Read Post »
Clinical TrialsDeucrictibant XR Shows 83% Reduction in HAE Attacks Deucrictibant XR Shows 83% Reduction in HAE Attacks Read Post »
Clinical TrialsArlo-cel Shows Strong Results in Hard-to-Treat Multiple Myeloma Arlo-cel Shows Strong Results in Hard-to-Treat Multiple Myeloma Read Post »
Health TidingsFDA Accepts Intellia’s Lonvo-z BLA with Priority Review for Hereditary An... FDA Accepts Intellia’s Lonvo-z BLA with Priority Review for Hereditary An... Read Post »
Health TidingsTozorakimab Reduces COPD Exacerbations Across Blood Eosinophil Levels in Ph... Tozorakimab Reduces COPD Exacerbations Across Blood Eosinophil Levels in Ph... Read Post »
Health TidingsETX101 Shows Sustained Seizure Reduction in Dravet Syndrome ETX101 Shows Sustained Seizure Reduction in Dravet Syndrome Read Post »
Health TidingsINBRX-106 Plus Pembrolizumab Shows Phase 2 HNSCC Benefit INBRX-106 Plus Pembrolizumab Shows Phase 2 HNSCC Benefit Read Post »
Clinical TrialsNovartis’ RNA Therapy Del-desiran Stumbles in Phase 3 DM1 Trial Novartis’ RNA Therapy Del-desiran Stumbles in Phase 3 DM1 Trial Read Post »
Health TidingsWHO Sets Phase 3 Targets for Dengue Drugs as Global Disease Burden Surges WHO Sets Phase 3 Targets for Dengue Drugs as Global Disease Burden Surges Read Post »
Clinical TrialsIMDELLTRA Plus Imfinzi Improves Survival in ES-SCLC IMDELLTRA Plus Imfinzi Improves Survival in ES-SCLC Read Post »
Clinical TrialsMosliciguat Demonstrates Strong Hemodynamic and Functional Efficacy in Phas... Mosliciguat Demonstrates Strong Hemodynamic and Functional Efficacy in Phas... Read Post »
Clinical TrialsCS-101 Base Editing Shows Results in SCD and β-Thalassemia CS-101 Base Editing Shows Results in SCD and β-Thalassemia Read Post »
Clinical TrialsUCB Presents Fenfluramine Data in Rare Epilepsies at EEC 2026 UCB Presents Fenfluramine Data in Rare Epilepsies at EEC 2026 Read Post »
Clinical TrialsResomelagon Shows Clearer Efficacy Signal in Post-Hoc Rheumatoid Arthritis ... Resomelagon Shows Clearer Efficacy Signal in Post-Hoc Rheumatoid Arthritis ... Read Post »
